Screening for Anti-lipase Properties of 37 Traditional Chinese Medicinal Herbs

Journal of the Chinese Medical Association

Volumn 73, Issue 6, 2010, Pages 319-324

  Zheng, Cheng Dong ^a,b   Duan, Ya Qing ^a,b   Gao, Jin Ming ^a   Ruan, Zhi Gang ^b  

^a Key Laboratory of Ecophysics and Department of Physics of Xinjiang Bingtuan   (China)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

Anti lipase activity; Anti obesity agents; Chinese herbal drugs; Prunella vulgaris L.; Rheum palmatum L.

Indexed keywords

2,4 DINITROPHENYLBUTYRATE; ACHYRANTHES BIDENTATA EXTRACT; ALISMA ORIENTAL EXTRACT; ANGELICA SINENSIS EXTRACT; ANTIOBESITY AGENT; ASTRAGALUS MEMBRANACEUS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; BUPLEURUM CHINENSE EXTRACT; BUTYRIC ACID; CORNUS OFFICINALIS EXTRACT; DIOSCOREA OPPOSITA EXTRACT; ECLIPTA PROSTRATA EXTRACT; EPHEDRA SINICA EXTRACT; EPIMEDIUM BREVICORNUM EXTRACT; FORSYTHIA SUSPENSA EXTRACT; LEONURUS JAPONICUS EXTRACT; LIGUSTICUM CHUANXIONG EXTRACT; LIGUSTRUM LUCIDUM EXTRACT; LUTEOLIN; MILLETTIA RETICUIATA EXTRACT; MULBERRY EXTRACT; PAEONIA LACTIFLORA EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PRUNELLA VULGARIS EXTRACT; QUERCETIN; RHUBARB EXTRACT; SAFFLOWER EXTRACT; SOUR ORANGE EXTRACT; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; HERBACEOUS AGENT;

ALISMA ORIENTAL; ARTICLE; BUPLEURUM CHINENSE; CHINESE HERB; CONCENTRATION RESPONSE; DIOSCOREA OPPOSITA; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; EPIMEDIUM BREVICORNUM; FORSYTHIA SUSPENSA; LEONURUS JAPONICUS; MILLETTIA RETICUIATA; SPECTROPHOTOMETRY; WEIGHT REDUCTION; ANTAGONISTS AND INHIBITORS; CHINESE MEDICINE;

DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; LIPASE; MEDICINE, CHINESE TRADITIONAL;

EID: 77954290399     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(10)70068-X     Document Type: Article

References (29)

1. Kopelman PG Obesity as a medical problem. Nature 2000, 404:635-643.
2. Jebb S Obesity: causes and consequences. Womens Health Med 2004, 1:38-41.
3. Finer N Medical consequences of obesity. Medicine 2006, 34:510-514.
4. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM Prevalence of overweight and obesity among US children, adolescents, and adults. 1999-2002. JAMA 2004, 291:2847-2850.
5. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195-2000.
6. Styne DM Childhood and adolescent obesity: prevalence and significance. Pediatr Clin North Am 2001, 48:823-854.
7. Glazer G Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch Intern Med 2001, 161:1814-1824.
8. Bray GA Medical therapy for obesity: current status and future hopes. Med Clin North Am 2007, 91:1225-1253.
9. Bray GA, Tartaglia LA Medicinal strategies in the treatment of obesity. Nature 2000, 404:672-677.
10. Cheetham SC, Jackson HC, Vickers SP, Dickinson K, Jones RB, Heal DJ Novel targets for the treatment of obesity: a review of progress. Drug Discov Today Ther Strateg 2004, 1:227-235.
11. Birari RB, Bhutani KK Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 2007, 12:879-889.
12. Mukherjee M Human digestive and metabolic lipases: a brief review. J Mol Catal B Enzym 2003, 22:369-376.
13. Thomson AB, De Pover A, Keelan M, Jarocka-Cyrta E, Clandinin MT Inhibition of lipid absorption as an approach to the treatment of obesity. Meth Enzymol 1997, 286:3-41.
14. Shi Y, Burn P Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 2004, 3:695-710.
15. Weigle DS Pharmacological therapy of obesity: past, present, and future. J Clin Endocrinol Metab 2003, 88:2462-2469.
16. Won SR, Kim SK, Kim YM, Lee PH, Ryu JH, Kim JW, Rhee HI Licochalcone A: a lipase inhibitor from the roots of Glycyrrhiza uralensis. Food Res Intern 2007, 40:1046-1050.
17. Zhao HL, Kim YS Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay. Arch Pharm Res 2004, 27:1048-1052.
18. Kwon CS, Sohn HY, Kim SH, Kim JH, Son KH, Lee JS, Lim JK, et al. Anti-obesity effects of Dioscorea nipponica Makino with lipase inhibitory activity in rodents. Biosci Biotechnol Biochem 2003, 67:1451-1456.
19. Ono Y, Hattori E, Fukaya Y, Imai S, Ohizumi Y Anti-obesity effect of Nelumbo ucifera leaves extract in mice and rats. J Ethnopharmacol 2006, 106:238-244.
20. Mosmuller EWJ, Van Heemst JDH, Van Delden CJ, Franssen MCR, Engbersen JFJ A new spectrophotometric method for the detection of lipase activity using 2,4-dinitrophenyl butyrate as a substrate. Biocatal Biotransformation 1992, 5:279-287.
21. Gargouri Y, Ransac S, Verger R Covalent inhibition of digestive lipases: an in vitro study. Biochim Biophys Acta 1997, 1344:6-37.
22. Sharma N, Sharma VK, Seo SY Screening of some medicinal plants for anti-lipase activity. J Ethnopharmacol 2005, 97:453-456.
23. Zheng J, He J, Ji B, Li Y, Zhang X Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pac J Clin Nutr 2007, 16(Suppl):427-431.
24. Xie WD, Xing DM, Zhao YN, Su H, Meng Z, Chen YY, Du LJ A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit. Eur J Pharmacol 2005, 510:113-120.
25. Zhang CB, Teng L, Shi Y, Jin JH, Xue YF, Shang KG, Gu J Effect of emodin on proliferation and differentiation of 3T3-L1 preadipocyte and FAS activity. Chin Med J 2002, 115:1035-1038.
26. Yang Y, Shang W, Zhou L, Jiang B, Jin H, Chen M Emodin with PPARgamma ligand-binding activity promotes adipocyte differentiation and increases glucose uptake in 3T3-Ll cells. Biochem Biophys Res 2007, 353:225-230.
27. Xing WW, Wu JZ, Jia M, Du J, Zhang H, Qin LP Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits. Biomed Pharmacother 2009, 63:457-462.
28. Du J, Sun LN, Xing WW, Huang BK, Jia M, Wu JZ, Zhang H, et al. Lipid-lowering effects of polydatin from Polygonum cuspi-datum in hyperlipidemic hamsters. Phytomedicine 2009, 16:652-658.
29. Liu J Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995, 49:57-68.